2018 PFS states:
1. Average LOM operating cash cost (Brook Hunt C1) of A$374/t (US$281/t).
2. It is assumed that all concentrate will be 100% payable and priced on a contractual basis with the average real price achieved LOM anticipated to be A$888/t (US$666/t) FOB Abidjan
Regarding 1.: We have pegmatite producers in Australia producing ore at A$350 (PLS) to A$300 (AJM) much less than MLL and still having financial problems. How viable is the highest number for MLL especially when it's a non-proven miner like PLS or AJM ??
Regarding 2.: As you all know current pricing for spodumene has since 2018 collapsed to less than A$500. Aussie producers like PLs and AJM find it difficult to sell their ore even at these low prices, even while they having offtake agreements and although they are next step to their clients in China. How viable will be for MLL without offtake agreement being in a landlocked country thousand of miles away from China to sell their ore profitably, given that they have to transport it by bulk carriers half the globe away (and pay for it) ??
Even the most optimistic person can clearly see that this project is impossible to move forward at this lithium market under any viable scenario so the wisest choice here is to sell and move to a better opportunity or stay trapped in this name maybe for years waiting for the winds to change.
- Forums
- ASX - By Stock
- FFX
- MLL has a questionable project under the currently depressed lithium market
MLL has a questionable project under the currently depressed lithium market
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online